The role of 68Ga-PSMA-PET/CT after a negative 18F-Choline PET/CT in biochemical relapse of prostate cancer: Initial experience

A Dhomps, W Sotlar, C Darcissac, M Fraysse… - 2019 - Soc Nuclear Med
1579 Introduction: For many years 18 F-Choline PET/CT has been used to stage and
restage prostate cancer while recently PSMA-PET/CT is more and more used in this …

68Ga-PSMA-PET/CT after a non-contributively 18F-Choline PET/CT in patients in biochemical relapse of prostate cancer

A Skanjeti, F Hallouard, A Dhomps, C Darcissac… - 2020 - Soc Nuclear Med
1258 Introduction: PSMA PET/CT is a recent nuclear medicine exam, particularly useful in
the management of patients followed for prostate cancer. The aim of this study was to …

68Ga-PSMA-11 PET-CT study in prostate cancer patients with biochemical recurrence and non-contributive 18F-Choline PET-CT: impact on therapeutic decision …

C Rousseau, A Michaud, M Barbaud… - European Journal of …, 2019 - hal.science
Aim/Introduction: The aim of this retrospective study was to investigate the impact of 68Ga-
PSMA-11 PET/CT on current management of recurrence prostate cancer patients with …

68Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patients

P Caroli, I Sandler, F Matteucci, U De Giorgi… - European journal of …, 2018 - Springer
Purpose We studied the usefulness of 68 Ga-prostate-specific membrane antigen (PSMA)
PET/CT for detecting relapse in a prospective series of patients with biochemical recurrence …

Additional value of PSMA-PET/CT in biochemical recurrence during follow-up of patients with prostate cancer.

C Bluemel, V Christian, A Buck, C Lapa, H Riedmiller… - 2015 - Soc Nuclear Med
1439 Objectives The aim of this study was to investigate the additional value of 68 Ga-PSMA-
PET/CT in case of choline-negative patients (pts) with biochemical relapse during follow-up …

68Ga-PSMA-PET/CT in patients with biochemical prostate cancer recurrence and negative 18F-choline-PET/CT

C Bluemel, M Krebs, B Polat, F Linke… - Clinical nuclear …, 2016 - journals.lww.com
Purpose Investigating the value of 68 Ga-PSMA-PET/CT in biochemically recurring prostate
cancer patients with negative 18 F-choline-PET/CT. Patients and Methods One hundred …

PSMA-11 PET/CT for Detection of Recurrent Prostate Cancer in Patients With Negative Choline PET/CT

F Pinot, R Le Pennec, R Abgral, F Blanc-Béguin… - Clinical Genitourinary …, 2023 - Elsevier
Abstract Introduction Prostate adenocarcinoma (CaP) is the leading cancer in men. After
curative treatment, from 27% to 53% of patients will experience biochemical recurrence …

Role of PSMA-PET/CT in Biochemical Relapse During Follow-Up of Prostate Cancer Patients

C Bluemel, C Vollmer, C Lapa… - EUROPEAN …, 2014 - opus.bibliothek.uni-augsburg.de
Aim The aim of this study was to investigate the additional value of 68Ga-PSMA-PET/CT in
case of choline-negative patients with biochemical relapse during follow-up. Methods From …

Diagnostic performance of 68Ga-PSMA PET/CT for restaging prostate cancer

M Hoffmann, H Wieler, J Müller-Hübenthal… - 2019 - Soc Nuclear Med
1568 Objectives: The aim of this study is to evaluate 68Ga-PSMA PET/CT for detecting
recurrent prostate carcinoma (PCa) in a large cohort of patients with biochemical recurrence …

[HTML][HTML] Prostate cancer imaging: when the game gets tough, the hard one gets done!

L Evangelista, M Sepulcri, M Maruzzo - European Journal of Nuclear …, 2018 - Springer
Recently, in the European Journal of Nuclear Medicine and Molecular Imaging, a paper
entitled:“68Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical …